Global Measle Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Measle Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Measle Vaccine industry chain, the market status of Hospital (Inactivated Vaccine, Attenuated Vaccine), Scientific Research (Inactivated Vaccine, Attenuated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Measle Vaccine.
Regionally, the report analyzes the Measle Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Measle Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Measle Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Measle Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Attenuated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Measle Vaccine market.
Regional Analysis: The report involves examining the Measle Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Measle Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Measle Vaccine:
Company Analysis: Report covers individual Measle Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Measle Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Measle Vaccine. It assesses the current state, advancements, and potential future developments in Measle Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Measle Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Measle Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Measle Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measle Vaccine, with price, sales, revenue and global market share of Measle Vaccine from 2019 to 2024.
Chapter 3, the Measle Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measle Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Measle Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measle Vaccine.
Chapter 14 and 15, to describe Measle Vaccine sales channel, distributors, customers, research findings and conclusion.
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Measle Vaccine industry chain, the market status of Hospital (Inactivated Vaccine, Attenuated Vaccine), Scientific Research (Inactivated Vaccine, Attenuated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Measle Vaccine.
Regionally, the report analyzes the Measle Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Measle Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Measle Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Measle Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Attenuated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Measle Vaccine market.
Regional Analysis: The report involves examining the Measle Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Measle Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Measle Vaccine:
Company Analysis: Report covers individual Measle Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Measle Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Measle Vaccine. It assesses the current state, advancements, and potential future developments in Measle Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Measle Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Measle Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Inactivated Vaccine
- Attenuated Vaccine
- Hospital
- Scientific Research
- Others
- Merck
- Biovac
- McKesson Medical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Measle Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measle Vaccine, with price, sales, revenue and global market share of Measle Vaccine from 2019 to 2024.
Chapter 3, the Measle Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measle Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Measle Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measle Vaccine.
Chapter 14 and 15, to describe Measle Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Measle Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measle Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Vaccine
1.3.3 Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Measle Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Measle Vaccine Market Size & Forecast
1.5.1 Global Measle Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Measle Vaccine Sales Quantity (2019-2030)
1.5.3 Global Measle Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measle Vaccine Product and Services
2.1.4 Merck Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business
2.2.3 Biovac Measle Vaccine Product and Services
2.2.4 Biovac Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovac Recent Developments/Updates
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business
2.3.3 McKesson Medical Measle Vaccine Product and Services
2.3.4 McKesson Medical Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 McKesson Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLE VACCINE BY MANUFACTURER
3.1 Global Measle Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Measle Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Measle Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Measle Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Measle Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Measle Vaccine Manufacturer Market Share in 2023
3.5 Measle Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measle Vaccine Market: Region Footprint
3.5.2 Measle Vaccine Market: Company Product Type Footprint
3.5.3 Measle Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measle Vaccine Market Size by Region
4.1.1 Global Measle Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Measle Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Measle Vaccine Average Price by Region (2019-2030)
4.2 North America Measle Vaccine Consumption Value (2019-2030)
4.3 Europe Measle Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Measle Vaccine Consumption Value (2019-2030)
4.5 South America Measle Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Measle Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Measle Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Measle Vaccine Consumption Value by Type (2019-2030)
5.3 Global Measle Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measle Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Measle Vaccine Consumption Value by Application (2019-2030)
6.3 Global Measle Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Measle Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Measle Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Measle Vaccine Market Size by Country
7.3.1 North America Measle Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Measle Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Measle Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Measle Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Measle Vaccine Market Size by Country
8.3.1 Europe Measle Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Measle Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measle Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Measle Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Measle Vaccine Market Size by Region
9.3.1 Asia-Pacific Measle Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Measle Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Measle Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Measle Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Measle Vaccine Market Size by Country
10.3.1 South America Measle Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Measle Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measle Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Measle Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Measle Vaccine Market Size by Country
11.3.1 Middle East & Africa Measle Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Measle Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Measle Vaccine Market Drivers
12.2 Measle Vaccine Market Restraints
12.3 Measle Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measle Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measle Vaccine
13.3 Measle Vaccine Production Process
13.4 Measle Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measle Vaccine Typical Distributors
14.3 Measle Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Measle Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measle Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Vaccine
1.3.3 Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Measle Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Measle Vaccine Market Size & Forecast
1.5.1 Global Measle Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Measle Vaccine Sales Quantity (2019-2030)
1.5.3 Global Measle Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measle Vaccine Product and Services
2.1.4 Merck Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business
2.2.3 Biovac Measle Vaccine Product and Services
2.2.4 Biovac Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovac Recent Developments/Updates
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business
2.3.3 McKesson Medical Measle Vaccine Product and Services
2.3.4 McKesson Medical Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 McKesson Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLE VACCINE BY MANUFACTURER
3.1 Global Measle Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Measle Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Measle Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Measle Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Measle Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Measle Vaccine Manufacturer Market Share in 2023
3.5 Measle Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measle Vaccine Market: Region Footprint
3.5.2 Measle Vaccine Market: Company Product Type Footprint
3.5.3 Measle Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measle Vaccine Market Size by Region
4.1.1 Global Measle Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Measle Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Measle Vaccine Average Price by Region (2019-2030)
4.2 North America Measle Vaccine Consumption Value (2019-2030)
4.3 Europe Measle Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Measle Vaccine Consumption Value (2019-2030)
4.5 South America Measle Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Measle Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Measle Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Measle Vaccine Consumption Value by Type (2019-2030)
5.3 Global Measle Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measle Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Measle Vaccine Consumption Value by Application (2019-2030)
6.3 Global Measle Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Measle Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Measle Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Measle Vaccine Market Size by Country
7.3.1 North America Measle Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Measle Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Measle Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Measle Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Measle Vaccine Market Size by Country
8.3.1 Europe Measle Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Measle Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measle Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Measle Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Measle Vaccine Market Size by Region
9.3.1 Asia-Pacific Measle Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Measle Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Measle Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Measle Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Measle Vaccine Market Size by Country
10.3.1 South America Measle Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Measle Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measle Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Measle Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Measle Vaccine Market Size by Country
11.3.1 Middle East & Africa Measle Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Measle Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Measle Vaccine Market Drivers
12.2 Measle Vaccine Market Restraints
12.3 Measle Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measle Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measle Vaccine
13.3 Measle Vaccine Production Process
13.4 Measle Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measle Vaccine Typical Distributors
14.3 Measle Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Measle Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Measle Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measle Vaccine Product and Services
Table 6. Merck Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Biovac Basic Information, Manufacturing Base and Competitors
Table 9. Biovac Major Business
Table 10. Biovac Measle Vaccine Product and Services
Table 11. Biovac Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biovac Recent Developments/Updates
Table 13. McKesson Medical Basic Information, Manufacturing Base and Competitors
Table 14. McKesson Medical Major Business
Table 15. McKesson Medical Measle Vaccine Product and Services
Table 16. McKesson Medical Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. McKesson Medical Recent Developments/Updates
Table 18. Global Measle Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 19. Global Measle Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 20. Global Measle Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Market Position of Manufacturers in Measle Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 22. Head Office and Measle Vaccine Production Site of Key Manufacturer
Table 23. Measle Vaccine Market: Company Product Type Footprint
Table 24. Measle Vaccine Market: Company Product Application Footprint
Table 25. Measle Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Measle Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 28. Global Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 29. Global Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 30. Global Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 31. Global Measle Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 32. Global Measle Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 33. Global Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 34. Global Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 35. Global Measle Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Global Measle Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Global Measle Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Measle Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 39. Global Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Measle Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 42. Global Measle Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 43. Global Measle Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 44. Global Measle Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 45. North America Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 46. North America Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 47. North America Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 48. North America Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 49. North America Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 50. North America Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 51. North America Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 52. North America Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Europe Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Europe Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Europe Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 56. Europe Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 57. Europe Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 58. Europe Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 59. Europe Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 62. Asia-Pacific Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 63. Asia-Pacific Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 64. Asia-Pacific Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 65. Asia-Pacific Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 66. Asia-Pacific Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 67. Asia-Pacific Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 68. Asia-Pacific Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 69. South America Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 70. South America Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 71. South America Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 72. South America Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 73. South America Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 74. South America Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 75. South America Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 78. Middle East & Africa Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 79. Middle East & Africa Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Middle East & Africa Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Middle East & Africa Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 82. Middle East & Africa Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 83. Middle East & Africa Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 84. Middle East & Africa Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 85. Measle Vaccine Raw Material
Table 86. Key Manufacturers of Measle Vaccine Raw Materials
Table 87. Measle Vaccine Typical Distributors
Table 88. Measle Vaccine Typical Customers
Table 1. Global Measle Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Measle Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measle Vaccine Product and Services
Table 6. Merck Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Biovac Basic Information, Manufacturing Base and Competitors
Table 9. Biovac Major Business
Table 10. Biovac Measle Vaccine Product and Services
Table 11. Biovac Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biovac Recent Developments/Updates
Table 13. McKesson Medical Basic Information, Manufacturing Base and Competitors
Table 14. McKesson Medical Major Business
Table 15. McKesson Medical Measle Vaccine Product and Services
Table 16. McKesson Medical Measle Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. McKesson Medical Recent Developments/Updates
Table 18. Global Measle Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 19. Global Measle Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 20. Global Measle Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Market Position of Manufacturers in Measle Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 22. Head Office and Measle Vaccine Production Site of Key Manufacturer
Table 23. Measle Vaccine Market: Company Product Type Footprint
Table 24. Measle Vaccine Market: Company Product Application Footprint
Table 25. Measle Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Measle Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 28. Global Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 29. Global Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 30. Global Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 31. Global Measle Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 32. Global Measle Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 33. Global Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 34. Global Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 35. Global Measle Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Global Measle Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Global Measle Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Measle Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 39. Global Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Measle Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 42. Global Measle Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 43. Global Measle Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 44. Global Measle Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 45. North America Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 46. North America Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 47. North America Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 48. North America Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 49. North America Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 50. North America Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 51. North America Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 52. North America Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Europe Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Europe Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Europe Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 56. Europe Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 57. Europe Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 58. Europe Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 59. Europe Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 62. Asia-Pacific Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 63. Asia-Pacific Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 64. Asia-Pacific Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 65. Asia-Pacific Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 66. Asia-Pacific Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 67. Asia-Pacific Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 68. Asia-Pacific Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 69. South America Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 70. South America Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 71. South America Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 72. South America Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 73. South America Measle Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 74. South America Measle Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 75. South America Measle Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 76. South America Measle Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 77. Middle East & Africa Measle Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 78. Middle East & Africa Measle Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 79. Middle East & Africa Measle Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Middle East & Africa Measle Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Middle East & Africa Measle Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 82. Middle East & Africa Measle Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 83. Middle East & Africa Measle Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 84. Middle East & Africa Measle Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 85. Measle Vaccine Raw Material
Table 86. Key Manufacturers of Measle Vaccine Raw Materials
Table 87. Measle Vaccine Typical Distributors
Table 88. Measle Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Measle Vaccine Picture
Figure 2. Global Measle Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Measle Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Vaccine Examples
Figure 5. Attenuated Vaccine Examples
Figure 6. Global Measle Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Measle Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Scientific Research Examples
Figure 10. Others Examples
Figure 11. Global Measle Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Measle Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Measle Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Measle Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Measle Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Measle Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Measle Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Measle Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Measle Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Measle Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Measle Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Measle Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Measle Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Measle Vaccine Market Drivers
Figure 74. Measle Vaccine Market Restraints
Figure 75. Measle Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Measle Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Measle Vaccine
Figure 79. Measle Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Measle Vaccine Picture
Figure 2. Global Measle Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Measle Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Vaccine Examples
Figure 5. Attenuated Vaccine Examples
Figure 6. Global Measle Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Measle Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Scientific Research Examples
Figure 10. Others Examples
Figure 11. Global Measle Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Measle Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Measle Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Measle Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Measle Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Measle Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Measle Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Measle Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Measle Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Measle Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Measle Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Measle Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Measle Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Measle Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Measle Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Measle Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Measle Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Measle Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Measle Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Measle Vaccine Market Drivers
Figure 74. Measle Vaccine Market Restraints
Figure 75. Measle Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Measle Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Measle Vaccine
Figure 79. Measle Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
